Kubona Iburyo Kuvura karuta kare kare ya kanseri ya kanseri hafi yanjye

Iki gitabo cyuzuye kigufasha kuyobora ibintu bigoye byo gushakisha Kanseri idakamyo ntoya (NSCLC) Amahitamo hafi yawe. Turashakisha uburyo butandukanye bwo kuvura, gutekereza kubihitamo ubwitonzi bukwiye, nubutunzi bwo gufasha urugendo rwawe.

Gusobanukirwa kanseri ntoya y'ibihaha

NCCLC ni iki?

Kanseri idafite ibihaha mito ni ubwoko bwa kanseri y'ibihaha, ibaruramari bagera kuri 80-85% bya kanseri y'ibihaha yose. Yashyizwe mubyiciro byinshi, buri kimwe gifite imico idasanzwe itezimbere. Kumenya hakiri kare ni ngombwa kugirango umusaruro wateze imbere. Gusobanukirwa subtype yawe yihariye nintambwe yingenzi muguhitamo inzira nziza ya Kuvura karuta kare kare ya kanseri ya kanseri hafi yanjye.

Gutegura no gusuzuma

Gutegura neza - Kugena urugero rwa kanseri ikwirakwira - ni ngombwa mugutegura Kuvura karuta kare kare ya kanseri ya kanseri hafi yanjye. Ibi bikubiyemo ibizamini bitandukanye, harimo ibisigazwa byamashusho (CT, amatungo), biopsies, n'ibizamini byamaraso. Icyiciro gitegeka uburyo bukwiye bwo kuvura. Kurugero, Otation-Stage NcSlc irashobora kubazwa no kubaga wenyine, mugihe ibyiciro byateye imbere bishobora gusaba guhuza imiti.

Amahitamo yo kuvura kuri NSCLC

Kubaga

Gukuraho ubwicanyi ni uburyo bwibanze bwo kuvura bwa mbere NSCLC. Inzira yihariye iterwa ahanini na tumor hamwe nubunini. Ibi birashobora kuba birimo Lobectomy (Gukuraho Lobe ya Lobe), Pneumonectomy (Gukuraho Ibihaha byose), cyangwa Kubohora (kuvanaho igice gito cyibihaha). Nyuma yo kubagwa, gusubiza mu buzima busanzwe ni ngombwa kugirango dukire.

Chimiotherapie

Chimitherapie ikoresha ibiyobyabwenge kugirango yice kanseri. Bikunze gukoreshwa mbere yo kubagwa (Neoadjuight) kugirango ugabanye ikibyimba, nyuma yo kubagwa (adkun) kugirango ukureho kanseri zisigaye, cyangwa nkubwito bwa NSCLC yateye imbere. Ibiyobyabwenge bisanzwe bya BECLC kuri NSCLC birimo Cisplatin, Carboppplatin, Paclitaxel, na Docetaxel. Ingaruka zo kuruhande ziratandukanye ariko akenshi zishobora gucungwa no kwitabwaho.

Imivugo

Umuvugizi w'imirasire ukoresha imirasire y'ingufu nyinshi zo kwangiza no gusenya ingirabuzimafatizo. Irashobora gukoreshwa wenyine, mbere cyangwa nyuma yo kubaga, cyangwa hamwe na chimiotherapie. Imirasire ya Beam yo hanze ikoreshwa cyane, itanga imirasire iva mumashini hanze yumubiri. Rimwe na rimwe, brachytherapy (imirasire y'imbere) irashobora gusuzumwa.

IGITABO

Igitekerezo cyibiyobyabwenge byibanda kuri molekile zihariye muri kanseri, zikabangamira imikurire yabo no kubaho. Izi mvugo zirimo gukora neza cyane kubarwayi ba NSCLC hamwe nibice byihariye bya genetike, nka egfr, alk, cyangwa ros1 ihinduka. Kwipimisha bisanzwe kugirango tumenye ihinduka ni ngombwa kugirango tumenye ibyangombwa byo kwibasirwa. Ingero zirimo osimertib (Tagsomaso), cnzitinib (xalkori), na aftinib (gilotrif).

Impfuya

Umuvumo wibiryo byumubiri wumubiri wumubiri wo kurwanya kanseri. Ikora mu kuzamura ubushobozi bwa sisitemu yubudahangarwa bwo kumenya no gutera ingirabuzimafatizo za kanseri. Ibiyobyabwenge, nka pembrorzimab (keytruda) na nivolumab (otdivo), bigira akamaro kubarwayi bamwe ba NSCLC, akenshi bahuza na chimitherapie cyangwa ubundi buvuzi. Ingaruka zo kuruhande zishobora kuba zirimo umunaniro, uruhu rutera, hamwe nibibazo bibi.

Kubona uburyo bwiza hafi yawe

Guhitamo ikigo cyo kuvura

Guhitamo ikigo cyemewe cya oncology kiratangaje. Shakisha ibigo hamwe nababitabilizi b'inararibonye, ​​ikoranabuhanga ryateye imbere, hamwe na track yanditswe mu kuvura NSCLC. Tekereza ku bintu nk'ibiri mu rugo rwawe, izina ry'ikigo, kandi riboneka ku byavugiye byihariye, ibigeragezo by'ubuvuzi, na serivisi zifasha. Reba ibisobanuro kumurongo hanyuma ushake ibyifuzo byumuganga wawe wibanze cyangwa umwuga wizewe.

Ibigeragezo by'amavuriro

Kwitabira ibigeragezo byubuvuzi bitanga uburyo bwo kugabanya-ubuvuzi butaraboneka cyane. Ibi bigeragezo byateguwe neza kugirango ugerageze mubarezishya no kunoza ibisubizo byumuvumo. Oncologue yawe irashobora kugufasha kumenya niba urubanza rwabavururu rubereye uko ibintu bimeze. Urashobora kandi gushakisha ubumuga bwo kuburanirwa nka Clinicaltrials.gog kugirango ubone ubushakashatsi bukoreshwa.

Inkunga n'umutungo

Kuyobora Isuzuma rya Kanseri birashobora kugorana. Shakisha inkunga y'amarangamutima kandi ifatika binyuze mu matsinda ashyigikira, imiryango ifatika (urugero, ishyirahamwe ry'ubuhaha ry'abanyamerika, urufatiro rwa kanseri y'ibihaha rwa Amerika), hamwe na serivisi z'ubujyanama. Ubu buryo butanga amakuru yingenzi, ubuyobozi, hamwe no gutera inkunga amarangamutima kubarwayi nimiryango yabo.

ICYITONDERWA

Aya makuru ni kubumenyi rusange kandi ntabwo ari inama zubuvuzi. Ni ngombwa kugisha inama oncologue cyangwa umwuga wubuvuzi kubijyanye no kwisuzumisha, igenamigambi ryumuvuzi, no kwitaho bikomeje kuvura kanseri ntoya. Amakuru yatanzwe hano ntabwo asimbuza inama zubuvuzi zumwuga. Buri gihe ujye ushake inama za Muganga cyangwa abandi bashinzwe ubuzima bujuje ibisabwa mubibazo byose ushobora kuba ufite bijyanye nubuvuzi.

Kubindi bisobanuro cyangwa gushakisha uburyo bwo kwivuza mukigo cyubushakashatsi bwa kanseri, sura Shandong Baofa Kanseri Ikigo cyubushakashatsi.